'I was sick with cramps but people didn't believe the pain was real'
Her symptoms worsened over time, with the pain becoming so intense it would leave her vomiting and breaking out in cold sweats.
Britt says her concerns were dismissed and she lived in pain for more than a decade before finally being diagnosed with adenomyosis – a common but under-recognised womb condition that experts warn is still being routinely missed.
'I would get labour-type contractions, and I'd be physically sick from the pain,' Britt told STV News.
'It got to the point where I had to plan my life around my period. I knew it wasn't normal, but no one took it seriously.'
Despite repeated visits to her GP, it took over 15 years before Britt was diagnosed. When she finally received treatment, doctors found her uterus was the size of someone who had given birth multiple times, despite her never having been pregnant.
Britt was initially diagnosed with endometriosis, another common but often misunderstood condition.
It was only after a second surgery that she was diagnosed with adenomyosis – a condition where the lining of the uterus grows into the muscular wall, often causing the womb to enlarge and thicken.
'The only cure right now is a hysterectomy,' she said. 'That's not a choice anyone should be forced into just to get relief. You're essentially losing an organ.'
Now running a support group for others with endometriosis and adenomyosis, Britt says one of the most difficult parts of the journey is not being believed, even by close friends and family.
'So many women in our group say the same thing, people around them don't believe the pain is real. That's heartbreaking. It makes you feel invisible.'
Experts say adenomyosis could affect as many as one in ten women, but diagnosis rates remain low due to a lack of awareness and limited diagnostic tools.
Dr Varsha Jain, a clinical research fellow at the University of Edinburgh, is among those calling for more investment in non-invasive testing.
'Historically, adenomyosis was only diagnosed after a hysterectomy, which means many women were simply missed,' she said. 'We're now working on better imaging and early detection, but we need more research, and more funding to properly understand this disease.'
The Scottish Government says women's health is a top priority.
Women's health minister Jenni Minto told STV News that a second phase of the Women's Health Plan is now in development, with £250,000 earmarked for research into menstrual health conditions, including adenomyosis.
For Britt, that support can't come soon enough.
'When you're in chronic pain all the time, you lose your sense of self,' she said. 'I want other women to know they're not alone. There's a whole community out there and we deserve better.'
Get all the latest news from around the country Follow STV News
Scan the QR code on your mobile device for all the latest news from around the country
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Leader Live
6 hours ago
- Leader Live
Weight loss jab Mounjaro linked to lower dementia risk
Academics said the benefits of drugs such as Wegovy and Mounjaro – including for managing weight and blood sugar levels – are well known, but other health benefits of the popular drugs remain 'unclear'. People with type 2 diabetes and obesity who are taking the drugs are also less likely to die prematurely, researchers found. The study saw experts from Taiwan examine date on 60,000 people from around the world, with an average age of 58, who had type 2 diabetes and obesity. Key differences between three weight-loss injections: Mounjaro, Wegovy, and Ozempic. Around half were given GLP agonist drugs semaglutide and tirzepatide – which are sold under the brand names Wegovy and Mounjaro. Semaglutide is also the main ingredient for the type 2 diabetes drug Ozempic. GLP agonists can reduce a person's appetite; slow down their digestion; reduce the amount of sugar the liver makes and they help the body to make more insulin when needed. The other half used other anti-diabetic medication. 📢Important update Eligible people in #Dorset will be able to access Tirzepatide (Mounjaro) weight management medication from autumn 2025. ✅Around 1,000 people in Dorset will qualify under strict national criteria ✅No need to contact your doctor More: During a seven-year follow-up period, researchers found that people given the GLP agonist drugs appeared to have a 37% lower risk of dementia and a 19% reduced risk of stroke. They were also 30% less likely to die during the follow-up period. And when researchers looked at the data further they found even greater benefits in people aged 60 or older, women, and those with a body mass index score of 30 to 40. They found no differences in Parkinson's disease or brain bleeds. The academics said their findings suggest 'potential neuroprotective and cerebrovascular benefits' of the drugs but they called for more studies to confirm the findings. Recommended reading: 'These findings suggest that semaglutide and tirzepatide may offer neuroprotective and cerebrovascular benefits beyond glycemic control, potentially improving long-term cognitive and survival outcomes in adults with type 2 diabetes and obesity,' they wrote in the journal JAMA Network Open. Commenting on the study, Professor Tara Spires-Jones, director of the Centre for Discovery Brain Sciences at the University of Edinburgh and group leader in the UK Dementia Research Institute, said: 'This is a very interesting study adding to evidence that GLP1 receptor agonists are associated with a lower risk of dementia in people with type 2 diabetes and obesity. 'This type of study cannot determine whether the drugs reduced disease risk by directly protecting the brain. 'It is highly likely that effectively treating type 2 diabetes and obesity would reduce dementia and stroke risk as they are known risk factors for these conditions. 'Further work is needed including randomised clinical trials to confirm these drugs are protective in people with diabetes and obesity and other trials are needed to determine whether these drugs will be protective in people who do not have type 2 diabetes and obesity.' Recommended reading: Dr Richard Oakley, associate director of research and innovation at Alzheimer's Society, said: 'It is well established that diabetes and obesity can increase your risk of developing dementia. 'This study supports existing evidence that shows these drugs may reduce dementia risk, particularly for people aged 60 and over who are living with type 2 diabetes and obesity. 'Although interesting, we can't draw conclusions from this study alone as it is an observational study, only a small number of people who took part went on to develop dementia and as the impact of these drugs on different types of dementia is not clear. 'There are clinical trials currently looking at whether drugs like these can be used to treat early-stage Alzheimer's disease, so this is a really exciting area being explored in the research fight against dementia.'
STV News
10 hours ago
- STV News
Fire crews battling blaze at abandoned hospital
Fire crews are battling a blaze within an abandoned hospital in Midlothian. Six fire engines were sent to the site of the former Rosslynlee Hospital in Midlothian around 1.15am on Tuesday. The mental health facility near Roslin, which dates back to the 1800s, was closed in 2011. Work is now under way to build new homes on the site. Members of the public are being advised to avoid the area. We are currently in attendance at a fire within the former Rosslynlee Hospital in Midlothian. Please avoid the area and, if you live locally, keep windows and doors closed where possible. (Posted at 10.45am on Tuesday, 15 July) — Scottish Fire and Rescue Service (@fire_scot) July 15, 2025 Local residents are also being urged to keep windows and doors closed where possible. A Scottish Fire and Rescue Service spokesperson said: 'We were alerted at 1.51am on Tuesday, July 15 to reports of a fire within a derelict building in Roslin, Midlothian. 'Operations Control mobilised six appliances to the former Rosslynlee Hospital, where crews currently remain on scene working to extinguish the fire.' STV News is now on WhatsApp Get all the latest news from around the country Follow STV News
The Herald Scotland
12 hours ago
- The Herald Scotland
Scottish NHS board's £269,000 pest control spend revealed
The figures, which were obtained by the Scottish Conservatives, found that pest control spending has risen year-on-year, from £47,000 in 2021/22 to £103,000 last year. During the four year time frame, 499 incidents involving 'crawling insects' were logged, as well as 178 reports of 'rodents', 128 reports of 'flying insects', and 461 reports of 'birds'. Money was also spent on cleaning up after 7 foxes, 9 bats, and 3 rabbits. Affected health care facilities included Aberdeen Royal Infirmary, Dr Gray's Hospital in Elgin, Woodend and Cornhill Hospitals in Aberdeen, and a number of smaller institutions across Aberdeenshire and Moray. Scottish Conservative MSP Alexander Burnett said: 'Dedicated NHS staff should not be forced to work in ageing, crumbling infested buildings that are putting the safety of themselves and their patients at risk. 'In people's hour of need, they should be safe from bugs and rodents roaming around freely in wards.' Read more: 'A grim reality': Glasgow City Council spent £106m to house homeless last year Scottish NHS board could face Court of Session over 'terrible' delays First Minister John Swinney to meet with Donald Trump during Scottish holiday Mr Burnett, who represents Aberdeenshire West in Holyrood, added: 'These repeated pest control call-outs are costing NHS Grampian a fortune, at a time when it is struggling to keep the lights on as it is. 'This substantial increase come at a time when the Scottish Government shamefully froze all new NHS building projects for two years, which has had a hugely detrimental impact on the North East. 'The Scottish Government must urgently give NHS Grampian the resources it needs to improve the North East estate and to ensure our hospitals are safe and clean.' The health board declared a 'critical incident' last November, due to 'extreme pressure' on Aberdeen Royal Infirmary, the area's largest hospital. During the incident, which lasted for a day, ambulance patients were diverted to other hospitals outside their area. NHS Grampian has been contacted for comment.
